Reassessing Quality-of-Life Instruments in the Evaluation of New Drugs Gordon H. GuyattRoman J. Jaeschke Current Opinion 15 November 2012 Pages: 621 - 626
The Danish Approach to Standards For Economic Evaluation Methodologies Anita AlbanMarlene GyldmarkJes Søgaard Leading Article 15 November 2012 Pages: 627 - 636
Assessing Antibacterial Pharmacoeconomics in the Intensive Care Unit Mary C. BirminghamJames M. HassettJoseph A. Paladino Review Article 15 November 2012 Pages: 637 - 647
Do Practice Guidelines Augment Drug Utilisation Review? Elizabeth A. ChrischillesKathleen Gondek Review Article 15 November 2012 Pages: 648 - 666
Application of the Findings of the European Stroke Prevention Study 2 (ESPS-2) to a New Zealand Ischaemic Stroke Cost Analysis Guy ScottHelen M. Scott Original Research Article 15 November 2012 Pages: 667 - 674
Measuring Patient Benefit From Botulinum Toxin in the Treatment of Dystonia Claire M. GudexMaurice R. HawthornePhilip O. F. Duffey Original Research Article 15 November 2012 Pages: 675 - 684
Quality Assessment of Economic Evaluations Published in Pharmacoeconomics Michael IskedjianKostas TrakasThomas R. Einarson Original Research Article 15 November 2012 Pages: 685 - 694
Costs of Treating Dystonias and Hemifacial Spasm with Botulinum Toxin A Richard C. DodelAnnette KirchnerWolfgang H. Oertel Original Research Article 15 November 2012 Pages: 695 - 706